Barriers of General Practitioner Regarding Helicobacter Pylori.

December 7, 2025 updated by: Mohanad Abd_Elaleem Sayed Amer, Assiut University

Knowledge, Attitude, Practices and Barriersof General Practitioner RegardingHelicobacter Pylori Diagnosis andTreatment

This study aims to evaluate the knowledge, attitudes, and clinical practices of general practitioners regarding the diagnosis and treatment of Helicobacter pylori infection. The study also seeks to identify the main barriers that prevent proper management of the condition. The central hypothesis is that gaps in knowledge and challenges in clinical practice contribute to variations in how general practitioners diagnose and treat H. pylori infection.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Not yet recruiting

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Detailed Description

This study explores the knowledge, attitudes, and practices of general practitioners regarding the diagnosis and treatment of Helicobacter pylori infection. It also examines the barriers that may affect appropriate clinical decision-making in managing this common gastrointestinal condition. By assessing physicians' understanding of recommended diagnostic techniques, treatment regimens, and follow-up strategies, the study aims to identify areas where education or system-level improvements may be needed.

The study hypothesizes that insufficient knowledge of current guidelines, limited access to diagnostic tests, and patient-related or system-related barriers contribute to inconsistent management of H. pylori infection among general practitioners. The findings may help inform future training programs and improve patient care outcomes.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Observational

Enrollment (Estimated)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
300

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact

The name and contact information for the person who can answer enrollment questions for a clinical study. Each location where the study is being conducted may also have a specific contact, who may be better able to answer those questions.

Study Contact Backup

  • Name: Mohamed Abdel-Sabour Mohamed Mekky Abdel-Sabour Mohamed Mekky
  • Phone Number: +20 10 12569456
  • Email: m.mekky@aun.edu.eg

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

cross-sectional, observational study.

Conducted in primary health care centers,

outpatient clinics, and general hospitals in Up

Egypt (e.g., Assiut, Sohag, Qena, Minya, Luxo

Aswan).

Description

Inclusion Criteria:

- Licensed general practitioners actively working primary health care centers, outpatients clinics and general hospitals in Upper Egypt( Assuit, Minya, Sohag, Qena, luxor and Aswan).

Exclusion Criteria:

  • Specialists in gastroenterology.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort

Group / Cohort

A group or subgroup of participants in an observational study that is assessed for biomedical or health outcomes.
Demographic , knowledge , Practices , attitude and barriers
Section A: demographic data (age, gender, years of experience, workplace) Section B: knowledge (transmission, symptoms, diagnostic methods,. treatment guidelines) Section C: attitude (perceived importance, confidence in diagnosis/treatment) Section D: practice (frequency of testing, treatment regimen used). Section E: barriers (e.g., Lack of resources, guidelines, time constraints, patient adherence)

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Knowledge
Time Frame: After history and examination by 1 hour.
Level of knowledge about H. pylori infection among General Practitioners" "Measured using a questionnaire of X items (e.g., 15 multiple-choice questions). The total knowledge score will be calculated as the percentage of correct answers."
After history and examination by 1 hour.
Attitudes
Time Frame: After history and examination by 1 hour.
Attitudes of General Practitioners towards diagnosis and treatment of H. pylori infection" "Measured using an X-point Likert scale (e.g., 5-point) on Y items (e.g., 10 statements). A mean score will be calculated for each participant."
After history and examination by 1 hour.
Practices
Time Frame: After history and examination by 1 hour.
Clinical practices of General Practitioners in managing H. pylori infection" "Measured using questions regarding frequency of testing and types of treatment regimens prescribed. Percentages for each practice will be calculated."
After history and examination by 1 hour.
Perceived Barriers
Time Frame: After history and examination by 1 hour.
Barriers reported by General Practitioners in diagnosing and treating H. pylori infection" "Measured using a checklist or Likert scale containing specific barriers (e.g., lack of resources, time constraints, guideline clarity). Frequencies or scores for each barrier will be calculated."
After history and examination by 1 hour.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Assiut University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
December 15, 2025

Primary Completion (Estimated)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
October 15, 2026

Study Completion (Estimated)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
December 15, 2026

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
September 29, 2025

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
December 7, 2025

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
December 16, 2025

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
December 16, 2025

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
December 7, 2025

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
September 1, 2025

More Information

Terms related to this study

Keywords

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • Helicobacter Pylori

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on H.Pylori Infection

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings